These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 33015987)

  • 1. Prognostic Significance of Thrombomodulin mRNA in High-Grade Soft Tissue Sarcomas after 10 years.
    Asanuma K; Nakamura T; Asanuma Y; Okamoto T; Kakimoto T; Yada Y; Hagi T; Kita K; Nakamura K; Matsumine A; Sudo A
    Orthop Surg; 2020 Dec; 12(6):1726-1732. PubMed ID: 33015987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum thrombomodulin as a metastatic and prognostic marker in soft tissue sarcomas.
    Asanuma K; Nakamura T; Asanuma Y; Kakimoto T; Yada Y; Hagi T; Kita K; Matsumine A; Sudo A
    Cancer Biomark; 2019; 26(2):163-170. PubMed ID: 31356193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Semi-Quantitative Calculations of Primary Tumor Metabolic Activity Using F-18 FDG PET/CT as a Predictor of Survival in 92 Patients With High-Grade Bone or Soft Tissue Sarcoma.
    Andersen KF; Fuglo HM; Rasmussen SH; Petersen MM; Loft A
    Medicine (Baltimore); 2015 Jul; 94(28):e1142. PubMed ID: 26181552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel splice variant of the stem cell marker LGR5/GPR49 is correlated with the risk of tumor-related death in soft-tissue sarcoma patients.
    Rot S; Taubert H; Bache M; Greither T; Würl P; Eckert AW; Schubert J; Vordermark D; Kappler M
    BMC Cancer; 2011 Oct; 11():429. PubMed ID: 21978106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can Multistate Modeling of Local Recurrence, Distant Metastasis, and Death Improve the Prediction of Outcome in Patients With Soft Tissue Sarcomas?
    Posch F; Leitner L; Bergovec M; Bezan A; Stotz M; Gerger A; Pichler M; Stöger H; Liegl-Atzwanger B; Leithner A; Szkandera J
    Clin Orthop Relat Res; 2017 May; 475(5):1427-1435. PubMed ID: 28083752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High bad and bcl-xL gene expression and combined bad, bcl-xL, bax and bcl-2 mRNA levels: molecular predictors for survival of stage 2 soft tissue sarcoma patients.
    Köhler T; Würl P; Meye A; Lautenschläger C; Bartel F; Borchert S; Bache M; Schmidt H; Holzhausen HJ; Taubert H
    Anticancer Res; 2002; 22(3):1553-9. PubMed ID: 12168836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of coagulation and fibrinolysis markers for benign and malignant soft tissue tumors.
    Asanuma K; Nakamura T; Hagi T; Okamoto T; Kita K; Nakamura K; Matsuyama Y; Yoshida K; Asanuma Y; Sudo A
    BMC Cancer; 2021 Apr; 21(1):364. PubMed ID: 33827473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Genomic Grade Index predicts postoperative clinical outcome in patients with soft-tissue sarcoma.
    Bertucci F; De Nonneville A; Finetti P; Perrot D; Nilbert M; Italiano A; Le Cesne A; Skubitz KM; Blay JY; Birnbaum D
    Ann Oncol; 2018 Feb; 29(2):459-465. PubMed ID: 29069276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low HIF-1α and low EGFR mRNA Expression Significantly Associate with Poor Survival in Soft Tissue Sarcoma Patients; the Proteins React Differently.
    Rot S; Taubert H; Bache M; Greither T; Würl P; Holzhausen HJ; Eckert AW; Vordermark D; Kappler M
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30513863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of mRNA levels of osteopontin splice variants in soft tissue sarcoma patients.
    Hahnel A; Wichmann H; Greither T; Kappler M; Würl P; Kotzsch M; Taubert H; Vordermark D; Bache M
    BMC Cancer; 2012 Apr; 12():131. PubMed ID: 22471890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble programmed death-ligand 1 rather than PD-L1 on tumor cells effectively predicts metastasis and prognosis in soft tissue sarcomas.
    Asanuma K; Nakamura T; Hayashi A; Okamoto T; Iino T; Asanuma Y; Hagi T; Kita K; Nakamura K; Sudo A
    Sci Rep; 2020 Jun; 10(1):9077. PubMed ID: 32493964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional variation in the survival of patients with a soft-tissue sarcoma of the extremity and trunk wall under a centralized care system : what has been the impact of national policies in the UK?
    Fujiwara T; Evans S; Stevenson J; Tsuda Y; Gregory J; Grimer RJ; Abudu S
    Bone Joint J; 2021 Sep; 103-B(9):1541-1549. PubMed ID: 34465152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Population-based Analysis of Lymph Node Metastasis in Extremity Soft Tissue Sarcoma: An Update.
    Gusho CA; Fice MP; O'Donoghue CM; Gitelis S; Blank AT
    J Surg Res; 2021 Jun; 262():121-129. PubMed ID: 33561723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic role of XTP1/DEPDC1B and SDP35/DEPDC1A in high grade soft-tissue sarcomas.
    Pollino S; Benassi MS; Pazzaglia L; Conti A; Bertani N; Righi A; Piccinni-Leopardi M; Picci P; Perris R
    Histol Histopathol; 2018 Jun; 33(6):597-608. PubMed ID: 29297565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of newer prognostic markers for adult soft tissue sarcomas.
    Levine EA; Holzmayer T; Bacus S; Mechetner E; Mera R; Bolliger C; Roninson IB; Das Gupta TK
    J Clin Oncol; 1997 Oct; 15(10):3249-57. PubMed ID: 9336362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic implications of PD-L1 expression in patients with soft tissue sarcoma.
    Kim C; Kim EK; Jung H; Chon HJ; Han JW; Shin KH; Hu H; Kim KS; Choi YD; Kim S; Lee YH; Suh JS; Ahn JB; Chung HC; Noh SH; Rha SY; Kim SH; Kim HS
    BMC Cancer; 2016 Jul; 16():434. PubMed ID: 27393385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What is a useful marker for predicting survival in patients with high-grade soft tissue sarcoma who have non-inflammatory conditions?
    Nakamura T; Asanuma K; Hagi T; Sudo A
    J Orthop Sci; 2024 Jul; 29(4):1125-1129. PubMed ID: 37537113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of preoperative [18-F] fluorodeoxyglucose (FDG) positron emission tomography (PET) imaging in patients with resectable soft tissue sarcomas.
    Schwarzbach MH; Hinz U; Dimitrakopoulou-Strauss A; Willeke F; Cardona S; Mechtersheimer G; Lehnert T; Strauss LG; Herfarth C; Büchler MW
    Ann Surg; 2005 Feb; 241(2):286-94. PubMed ID: 15650639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomerase activity and human telomerase reverse transcriptase mRNA expression are correlated with clinical aggressiveness in soft tissue tumors.
    Tomoda R; Seto M; Tsumuki H; Iida K; Yamazaki T; Sonoda J; Matsumine A; Uchida A
    Cancer; 2002 Sep; 95(5):1127-33. PubMed ID: 12209700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of hyperthermic isolated limb perfusion in the treatment of locally recurrent high-grade soft tissue sarcoma of the extremities.
    Farzaliyev F; Touma A; Taeger G; Steinau HU; Hardes J; Streitbürger A; Podleska LE
    World J Surg Oncol; 2020 Dec; 18(1):332. PubMed ID: 33349267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.